2-Bromobenzimidazole - CAS 54624-57-6
Catalog: |
BB028742 |
Product Name: |
2-Bromobenzimidazole |
CAS: |
54624-57-6 |
Synonyms: |
2-bromo-1H-benzimidazole; 2-bromo-1H-benzimidazole |
IUPAC Name: | 2-bromo-1H-benzimidazole |
Description: | 2-Bromobenzimidazole (CAS# 54624-57-6) is a 2-bromo substituted benzimidazole used in the preparation of benzimidazole nucleosides as antiviral agents. |
Molecular Weight: | 197.03 |
Molecular Formula: | C7H5BrN2 |
Canonical SMILES: | C1=CC=C2C(=C1)NC(=N2)Br |
InChI: | InChI=1S/C7H5BrN2/c8-7-9-5-3-1-2-4-6(5)10-7/h1-4H,(H,9,10) |
InChI Key: | PHPYXVIHDRDPDI-UHFFFAOYSA-N |
Boiling Point: | 346 °C at 760 mmHg |
Density: | 1.77 g/cm3 |
Appearance: | White to yellow solid |
MDL: | MFCD00160009 |
LogP: | 2.32540 |
GHS Hazard Statement: | H302 (82.61%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P310, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
CN-111635437-A | Palladium complex containing ortho-position carborane-based benzimidazole structure and preparation method and application thereof | 20200522 |
WO-2021151062-A1 | Heterocyclic compounds and uses thereof | 20200124 |
CN-111646983-A | Nitrogen-containing compound, organic electroluminescent device, and electronic device | 20191230 |
CN-111646983-B | Nitrogen-containing compound, organic electroluminescent device, and electronic device | 20191230 |
WO-2021135182-A1 | Nitrogen-containing compound, organic electroluminescence device and electronic apparatus | 20191230 |
PMID | Publication Date | Title | Journal |
22701601 | 20120101 | Application of consensus scoring and principal component analysis for virtual screening against β-secretase (BACE-1) | PloS one |
20481485 | 20100624 | Inhibition of protein kinase C-driven nuclear factor-kappaB activation: synthesis, structure-activity relationship, and pharmacological profiling of pathway specific benzimidazole probe molecules | Journal of medicinal chemistry |
17381174 | 20070301 | In silico binding free energy predictability by using the linear interaction energy (LIE) method: bromobenzimidazole CK2 inhibitors as a case study | Journal of chemical information and modeling |
Complexity: | 129 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 195.96361 |
Formal Charge: | 0 |
Heavy Atom Count: | 10 |
Hydrogen Bond Acceptor Count: | 1 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 195.96361 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 28.7 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.3 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Benzimidazoles
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS